Wellnex Life (ASX:WNX) managing director Zack Bozinovski admits that local investors don’t fully understand the power and ...

Pfizer Inc. is offering around 700 million shares in Haleon Plc, representing a roughly 7.7% stake in the maker of Sensodyne ...

Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. It was spun off from the British drugmaker ...

Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK (GSK.L), opens new tab and Pfizer's consumer healthcare businesses in 2019. It was spun off from ...

Panadol and Advil, which gained 17% in 2024, were up 0.7% at 369.7 pence in morning trade on Wednesday, in line with the broader FTSE 100. The sale represents nearly 7.7% of the issued share capital ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Panadol and Advil painkillers, and Centrum vitamins. Pfizer is a New York-based pharmaceutical and biotechnology firm. Haleon was formed in 2019 as a joint venture of Pfizer and GSK PLC's consumer ...

Haleon, known for brands such as Sensodyne, Panadol, and Advil, was created through the merger of GSK and Pfizer’s consumer healthcare businesses in 2019 and spun off as a standalone entity in 2022.

having been more than 30% when the former GSK joint venture business floated at 330p in July 2022. Weybridge-based Haleon, whose brands include Panadol, Sensodyne and Centrum, rose 2.3p to 369.4p ...